Stocktoria

Propanc Biopharma, Inc. PPCB

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2012-06-15 · LEI

Propanc Biopharma, Inc. statistics & valuation

Market cap$3.3M
P / B0.4×
Return on capital-192.9%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2017201820192020202120222023202420252026
Operating margin (%)
2017201820192020202120222023202420252026
Return on equity (%)
-423.70% -200.60% 2017201820192020202120222023202420252026
Shares outstanding
4.6M 92810 967993 258120 14.1M 220351 6.0M 7980 464471 3.3M 2017201820192020202120222023202420252026
Net debt ($)
$3.5M $4.7M $1.7M $1.5M $622328 $922371 $390539 $399325 $537921 2017201820192020202120222023202420252026
Share buybacks ($)
2017201820192020202120222023202420252026
Return on assets (%)
-8275.60% -9860.60% -5664.80% -4812.00% -15464.10% -3255.40% -4410.20% -2515.80% -300.10% -147.60% 2017201820192020202120222023202420252026
Free cash flow margin (%)
2017201820192020202120222023202420252026
Debt / equity (×)
0.04× 2017201820192020202120222023202420252026
EPS ($)
-$49.23 -$1.80 -$1420.53 -$371.22 -$17.62 2017201820192020202120222023202420252026

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Return on assets-147.6%-300.1%-2515.8%-4410.2%-3255.4%-15464.1%-4812.0%-5664.8%-9860.6%-8275.6%
Return on equity-200.6%-423.7%48.2%85.4%87.9%66.0%130.2%133.9%104.3%144.6%
Debt / equity—0.04×-0.11×-0.13×-0.31×-0.20×-0.43×-0.39×-0.70×-0.64×
Current ratio2.551.500.010.010.000.000.020.020.010.01

Computed from company filings · US · as of 2025-06-30. Facts plus Stocktoria's own computed scores — not investment advice.